Secretin-Stimulated Magnetic Resonance Cholangiopancreatography (S-MRCP) in Pancreatic Patients
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The aim of our study is to evaluate the utility of Secretin-Stimulated Magnetic Resonance
Cholangiopancreatography (S-MRCP) in detecting carcinoma and precancerous lesions in patients
with a significant family history of pancreatic adenocarcinoma. Our hypothesis is that S-MRCP
is superior to traditional computed tomography (CT) or magnetic resonance imaging (MRI) in
detecting early pancreatic neoplasms, and approaches the accuracy of endoscopic ultrasound
(EUS).